{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:34:58Z","timestamp":1762032898069},"reference-count":73,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.vaccine.2010.06.054","type":"journal-article","created":{"date-parts":[[2010,7,13]],"date-time":"2010-07-13T08:07:59Z","timestamp":1279008479000},"page":"5891-5899","source":"Crossref","is-referenced-by-count":20,"title":["Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice"],"prefix":"10.1016","volume":"28","author":[{"given":"Joseph N.","family":"Brewoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim D.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan T.","family":"Stinchcomb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge E.","family":"Osorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"September","key":"10.1016\/j.vaccine.2010.06.054_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1128\/MMBR.25.3.249-261.1961","article-title":"Pneumonic plague","author":"Meyer","year":"1961","journal-title":"Bacteriol Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2010.06.054_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"Yersinia pestis\u2014etiologic agent of plague","volume":"10","author":"Perry","year":"1997","journal-title":"Clin Microlbiol Rev"},{"key":"10.1016\/j.vaccine.2010.06.054_bib3","unstructured":"Human plague\u2014four states, 2006. MMWR Morb Mortal Wkly Rep 2006;55(September(34)):940-3."},{"issue":"August","key":"10.1016\/j.vaccine.2010.06.054_bib4","article-title":"Human plague occurrences in Africa: an overview from 1877 to 2008","author":"Neerinckx","year":"2009","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2010.06.054_bib5","first-page":"1115","article-title":"Human plague outbreak in two villages, Yunnan Province, China, 2005","volume":"38","author":"Yin","year":"2007","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"4","key":"10.1016\/j.vaccine.2010.06.054_bib6","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/jmedent\/30.4.758","article-title":"Reported cases of human plague infections in the United States, 1970-1991","volume":"30","author":"Craven","year":"1993","journal-title":"J Med Entomol"},{"issue":"January\u2013February (1)","key":"10.1016\/j.vaccine.2010.06.054_bib7","first-page":"87","article-title":"Outbreak of bubonic plague in Jacocha, Huancabamba, Peru","volume":"34","author":"Davalos","year":"2001","journal-title":"Revista da Sociedade Brasileira de Medicina Tropical"},{"issue":"July\u2013August (4)","key":"10.1016\/j.vaccine.2010.06.054_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0035-9203(00)90114-7","article-title":"An outbreak of plague including cases with probable pneumonic infection, Ecuador, 1998","volume":"94","author":"Gabastou","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2010.06.054_bib9","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1365-3156.2006.01677.x","article-title":"Epidemiological trends for human plague in Madagascar during the second half of the 20th century: a survey of 20,900 notified cases","volume":"11","author":"Migliani","year":"2006","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.vaccine.2010.06.054_bib10","doi-asserted-by":"crossref","first-page":"720","DOI":"10.7589\/0090-3558-33.4.720","article-title":"Plague in a complex of white-tailed prairie dogs and associated small mammals in Wyoming","volume":"33","author":"Anderson","year":"1997","journal-title":"J Wildl Dis"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2010.06.054_bib11","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1086\/313804","article-title":"Cases of cat-associated human plague in the Western US, 1977-1998","volume":"30","author":"Gage","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2010.06.054_bib12","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1128\/AAC.00306-06","article-title":"Resistance of Yersinia pestis to antimicrobial agents","volume":"50","author":"Galimand","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"September (10)","key":"10.1016\/j.vaccine.2010.06.054_bib13","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199709043371004","article-title":"Multidrug resistance in Yersinia pestis mediated by a transferable plasmid","volume":"337","author":"Galimand","year":"1997","journal-title":"N Engl J Med"},{"issue":"May (17)","key":"10.1016\/j.vaccine.2010.06.054_bib14","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1001\/jama.283.17.2281","article-title":"Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense","volume":"283","author":"Inglesby","year":"2000","journal-title":"JAMA"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2010.06.054_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/14760584.7.2.209","article-title":"Current challenges in the development of vaccines for pneumonic plague","volume":"7","author":"Smiley","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"July (30)","key":"10.1016\/j.vaccine.2010.06.054_bib16","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1016\/S0264-410X(01)00163-3","article-title":"Vaccination against bubonic and pneumonic plague","volume":"19","author":"Titball","year":"2001","journal-title":"Vaccine"},{"issue":"October (4\u20135)","key":"10.1016\/j.vaccine.2010.06.054_bib17","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0264-410X(00)00159-6","article-title":"A single dose sub-unit vaccine protects against pneumonic plague","volume":"19","author":"Williamson","year":"2000","journal-title":"Vaccine"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2010.06.054_bib18","first-page":"1081","article-title":"Detection and characterization of the plasmids of the plague microbe which determine the synthesis of pesticin I, fraction I antigen and \u201cmouse\u201d toxin exotoxin","volume":"19","author":"Protsenko","year":"1983","journal-title":"Genetika"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2010.06.054_bib19","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1128\/IAI.73.3.1532-1542.2005","article-title":"Antibody against V antigen prevents Yop-dependent growth of Yersinia pestis","volume":"73","author":"Philipovskiy","year":"2005","journal-title":"Infect Immun"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2010.06.054_bib20","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1128\/IAI.70.3.1453-1460.2002","article-title":"Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis","volume":"70","author":"Du","year":"2002","journal-title":"Infect Immun"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2010.06.054_bib21","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1128\/IAI.00105-08","article-title":"Yersinia pestis caf1 variants and the limits of plague vaccine protection","volume":"76","author":"Quenee","year":"2008","journal-title":"Infect Immun"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.06.054_bib22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1128\/IAI.61.1.23-31.1993","article-title":"Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha","volume":"61","author":"Nakajima","year":"1993","journal-title":"Infect Immun"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2010.06.054_bib23","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1128\/IAI.73.8.5152-5159.2005","article-title":"LcrV plague vaccine with altered immunomodulatory properties","volume":"73","author":"Overheim","year":"2005","journal-title":"Infect Immun"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.06.054_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.micpath.2006.09.003","article-title":"Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates","volume":"42","author":"Williamson","year":"2007","journal-title":"Microb Pathog"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2010.06.054_bib25","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1128\/IAI.64.11.4580-4585.1996","article-title":"Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis","volume":"64","author":"Anderson","year":"1996","journal-title":"Infect Immun"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2010.06.054_bib26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/mpat.1997.0141","article-title":"Expression of an F1\/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague","volume":"23","author":"Leary","year":"1997","journal-title":"Microb Pathog"},{"issue":"September\u2013October (5)","key":"10.1016\/j.vaccine.2010.06.054_bib27","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1021\/bp050098r","article-title":"Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague","volume":"21","author":"Powell","year":"2005","journal-title":"Biotechnol Prog"},{"issue":"November (47)","key":"10.1016\/j.vaccine.2010.06.054_bib28","doi-asserted-by":"crossref","first-page":"7984","DOI":"10.1016\/j.vaccine.2007.09.030","article-title":"Effect of adjuvants and route of immunizations on the immune response to recombinant plague antigens","volume":"25","author":"Uddowla","year":"2007","journal-title":"Vaccine"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2010.06.054_bib29","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1128\/IAI.73.6.3598-3608.2005","article-title":"Human immune response to a plague vaccine comprising recombinant F1 and V antigens","volume":"73","author":"Williamson","year":"2005","journal-title":"Infect Immun"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2010.06.054_bib30","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1128\/IAI.58.10.3262-3271.1990","article-title":"YopM inhibits platelet aggregation and is necessary for virulence of Yersinia pestis in mice","volume":"58","author":"Leung","year":"1990","journal-title":"Infect Immun"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2010.06.054_bib31","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1128\/IAI.67.4.1922-1928.1999","article-title":"Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice","volume":"67","author":"Benner","year":"1999","journal-title":"Infect Immun"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2010.06.054_bib32","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1128\/IAI.67.3.1533-1537.1999","article-title":"Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis","volume":"67","author":"Andrews","year":"1999","journal-title":"Infect Immun"},{"issue":"November (50)","key":"10.1016\/j.vaccine.2010.06.054_bib33","doi-asserted-by":"crossref","first-page":"6329","DOI":"10.1016\/j.vaccine.2008.09.031","article-title":"Single-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4+ cells are required at the time of challenge for optimal protection","volume":"26","author":"Chattopadhyay","year":"2008","journal-title":"Vaccine"},{"issue":"January (4)","key":"10.1016\/j.vaccine.2010.06.054_bib34","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.vaccine.2006.08.010","article-title":"An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge","volume":"25","author":"Palin","year":"2007","journal-title":"Vaccine"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2010.06.054_bib35","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1086\/507644","article-title":"Protective immunity against respiratory tract challenge with Yersinia pestis in mice immunized with an adenovirus-based vaccine vector expressing V antigen","volume":"194","author":"Chiuchiolo","year":"2006","journal-title":"J Infect Dis"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2010.06.054_bib36","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.4049\/jimmunol.178.2.1059","article-title":"Oral vaccination with salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague","volume":"178","author":"Yang","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.06.054_bib37","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0264-410X(02)00557-1","article-title":"Recombinant raccoon pox vaccine protects mice against lethal plague","volume":"21","author":"Osorio","year":"2003","journal-title":"Vaccine"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2010.06.054_bib38","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1128\/IAI.72.9.5502-5505.2004","article-title":"Protection of black-tailed prairie dogs (Cynomys ludovicianus) against plague after voluntary consumption of baits containing recombinant raccoon poxvirus vaccine","volume":"72","author":"Mencher","year":"2004","journal-title":"Infect Immun"},{"issue":"December (2)","key":"10.1016\/j.vaccine.2010.06.054_bib39","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.vaccine.2009.10.043","article-title":"Further development of raccoon poxvirus-vectored vaccines against plague (Yersinia pestis)","volume":"28","author":"Rocke","year":"2009","journal-title":"Vaccine"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2010.06.054_bib40","doi-asserted-by":"crossref","first-page":"930","DOI":"10.7589\/0090-3558-44.4.930","article-title":"Immunization of black-tailed prairie dog against plague through consumption of vaccine-laden baits","volume":"44","author":"Rocke","year":"2008","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.vaccine.2010.06.054_bib41","first-page":"375","article-title":"The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the eparenteral vaccination and behavior in organisms with a debiliteated defence mechanism (author's transl)","volume":"167","author":"Mayr","year":"1978","journal-title":"Zentralbl Bakteriol"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2010.06.054_bib42","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.copbio.2004.09.001","article-title":"Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?","volume":"15","author":"Drexler","year":"2004","journal-title":"Curr Opin Biotechnol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2010.06.054_bib43","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/sj.cgt.7700937","article-title":"Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine","volume":"13","author":"Garcia-Hernandez","year":"2006","journal-title":"Cancer Gene Ther"},{"issue":"June (11 Pt 1)","key":"10.1016\/j.vaccine.2010.06.054_bib44","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1158\/1078-0432.CCR-05-2732","article-title":"Vaccination of colorectal cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) induces immune responses which correlate with disease control: a phase I\/II trial","volume":"12","author":"Harrop","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"May (Pt 5)","key":"10.1016\/j.vaccine.2010.06.054_bib45","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1099\/0022-1317-72-5-1031","article-title":"Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence","volume":"72","author":"Meyer","year":"1991","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2010.06.054_bib46","first-page":"195","article-title":"Novel vaccinia vector derived from the host range restricted and highly attenuated MVA strain of vaccinia virus","volume":"84","author":"Sutter","year":"1995","journal-title":"Dev Biol Stand"},{"issue":"August (11)","key":"10.1016\/j.vaccine.2010.06.054_bib47","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/0264-410X(94)90341-7","article-title":"A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus","volume":"12","author":"Sutter","year":"1994","journal-title":"Vaccine"},{"issue":"February (12)","key":"10.1016\/j.vaccine.2010.06.054_bib48","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.vaccine.2004.08.050","article-title":"Biodistribution and persistence of an MVA-vectored candidate HIV vaccine in SIV-infected rhesus macaques and SCID mice","volume":"23","author":"Hanke","year":"2005","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2010.06.054_bib49","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00705-003-0006-z","article-title":"Tissue distribution of the Ankara strain of vaccinia virus (MVA) after mucosal or systemic administration","volume":"148","author":"Ramirez","year":"2003","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2010.06.054_bib50","doi-asserted-by":"crossref","unstructured":"Earl PL, Cooper N, Wyatt LS, Moss B, Carroll MW. Preparation of cell cultures and vaccinia virus stocks. Current protocols in protein science \/editorial board, John E Coligan, et al. 2001 May;Chapter 5:Unit5 12.","DOI":"10.1002\/0471140864.ps0512s13"},{"key":"10.1016\/j.vaccine.2010.06.054_bib51","doi-asserted-by":"crossref","unstructured":"Earl PL, Moss B, Wyatt LS, Carroll MW. Generation of recombinant vaccinia viruses. Current protocols in molecular biology \/edited by Frederick M Ausubel, et al. 2001 May;Chapter 16:Unit16 7.","DOI":"10.1002\/0471142727.mb1617s43"},{"issue":"June (1\u20133)","key":"10.1016\/j.vaccine.2010.06.054_bib52","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10616-005-3795-y","article-title":"Current status for high titre poxvirus stock preparation in CEF under serum-free medium conditions: implication for vaccine development","volume":"48","author":"Gilbert","year":"2005","journal-title":"Cytotechnology"},{"issue":"August (15)","key":"10.1016\/j.vaccine.2010.06.054_bib53","doi-asserted-by":"crossref","first-page":"8394","DOI":"10.1128\/JVI.77.15.8394-8407.2003","article-title":"Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L","volume":"77","author":"Hornemann","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.06.054_bib54","first-page":"493","article-title":"A simple method of estimating fifty percent points","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2010.06.054_bib55","first-page":"319","article-title":"Body condition scoring: a rapid and accurate method for assessing health status in mice","volume":"49","author":"Ullman-Cullere","year":"1999","journal-title":"Lab Anim Sci"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2010.06.054_bib56","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1574-695X.1998.tb01168.x","article-title":"Macromolecular organisation of recombinant Yersinia pestis F1 antigen and the effect of structure on immunogenicity","volume":"21","author":"Miller","year":"1998","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"April","key":"10.1016\/j.vaccine.2010.06.054_bib57","first-page":"391","article-title":"Association-dissociation processes and supermolecular organisation of the capsule antigen (protein F1) of Yersinia pestis","volume":"4","author":"Vorontsov","year":"1990","journal-title":"Biomed Sci"},{"issue":"July (11\u201312)","key":"10.1016\/j.vaccine.2010.06.054_bib58","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine","volume":"16","author":"Heath","year":"1998","journal-title":"Vaccine"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2010.06.054_bib59","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1517\/14712598.4.6.965","article-title":"Yersinia pestis (plague) vaccines","volume":"4","author":"Titball","year":"2004","journal-title":"Expert Opin Biol Ther"},{"issue":"June (9)","key":"10.1016\/j.vaccine.2010.06.054_bib60","first-page":"857","article-title":"Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens","volume":"13","author":"Schirmbeck","year":"1995","journal-title":"Vaccine"},{"issue":"Pt 9","key":"10.1016\/j.vaccine.2010.06.054_bib61","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/brain\/124.9.1821","article-title":"Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle","volume":"124","author":"Gherardi","year":"2001","journal-title":"Brain"},{"issue":"March (14)","key":"10.1016\/j.vaccine.2010.06.054_bib62","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.vaccine.2006.07.035","article-title":"Viral vectors for malaria vaccine development","volume":"25","author":"Li","year":"2007","journal-title":"Vaccine"},{"issue":"8\u201310","key":"10.1016\/j.vaccine.2010.06.054_bib63","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/10611860410001670062","article-title":"Raccoon poxvirus as a mucosal vaccine vector for domestic cats","volume":"11","author":"Osorio","year":"2003","journal-title":"J Drug Target"},{"issue":"April (1)","key":"10.1016\/j.vaccine.2010.06.054_bib64","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2249.1999.00859.x","article-title":"An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model","volume":"116","author":"Williamson","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2010.06.054_bib65","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1128\/IAI.01860-05","article-title":"Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV","volume":"74","author":"DeBord","year":"2006","journal-title":"Infect Immun"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2010.06.054_bib66","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1128\/CVI.00398-06","article-title":"Development of in vitro correlate assays of immunity to infection with Yersinia pestis","volume":"14","author":"Bashaw","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2010.06.054_bib67","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1128\/IAI.73.11.7304-7310.2005","article-title":"Cell-mediated protection against pulmonary Yersinia pestis infection","volume":"73","author":"Parent","year":"2005","journal-title":"Infect Immun"},{"issue":"June (4572)","key":"10.1016\/j.vaccine.2010.06.054_bib68","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/1791246a0","article-title":"Virulence of Pasteurella pestis","volume":"179","author":"Burrows","year":"1957","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2010.06.054_bib69","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4049\/jimmunol.160.2.870","article-title":"CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen","volume":"160","author":"Davis","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.06.054_bib70","first-page":"156","article-title":"Pathology of experimental pneumonic plague produced by fraction-1 positive and fraction-1 negative Yersinia pestis in African green monkeys","volume":"120","author":"Davis","year":"1996","journal-title":"Arch Pathol Lab Med"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2010.06.054_bib71","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1099\/00222615-42-4-264","article-title":"Virulent non-capsulate Yersinia pestis variants constructed by insertion mutagenesis","volume":"42","author":"Drozdov","year":"1995","journal-title":"J Med Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.06.054_bib72","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0035-9203(75)90039-5","article-title":"Letter: cryptic infection of rats with non-encapsulated variants of Yersinia pestis","volume":"69","author":"Williams","year":"1975","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2010.06.054_bib73","first-page":"408","article-title":"An unusual strain of Pasteurella pestis isolated from a fatal human case of plague","volume":"23","author":"Winter","year":"1960","journal-title":"Bull World Health Organ"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10008650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10008650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T02:06:31Z","timestamp":1685671591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10008650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":73,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0264410X10008650"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.06.054","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}